Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
Title:
Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
Author:
Miyaoka, Tsuyoshi Wake, Rei Furuya, Motohide Liaury, Kristian Ieda, Masa Kawakami, Kazunori Tsuchie, Keiko Inagaki, Takuji Horiguchi, Jun